| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 116.920 | 71.921 | 11.534 | - | - | 0 | 0 | 0 |
| Total Income - EUR | - | - | 116.920 | 71.921 | 11.534 | - | - | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 121.197 | 85.978 | 17.459 | - | - | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | -4.277 | -14.057 | -5.925 | - | - | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | -5.446 | -14.776 | -6.058 | - | - | 0 | 0 | 0 |
| Employees | - | - | 3 | 4 | 1 | - | - | 0 | 0 | 0 |
Check the financial reports for the company - Mdy Bio Dorady Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 107 | 105 | - | - | 0 | 0 | 0 |
| Current Assets | - | - | 16.792 | 29.649 | 35.119 | - | - | 33.901 | 33.798 | 35.178 |
| Inventories | - | - | 15.165 | 28.966 | 33.881 | - | - | 32.581 | 32.482 | 32.300 |
| Receivables | - | - | 1.507 | 495 | 1.202 | - | - | 1.286 | 1.282 | 2.844 |
| Cash | - | - | 121 | 188 | 36 | - | - | 34 | 34 | 34 |
| Shareholders Funds | - | - | -5.402 | -20.079 | -25.748 | - | - | -26.568 | -26.487 | -26.339 |
| Social Capital | - | - | 44 | 43 | 42 | - | - | 41 | 40 | 40 |
| Debts | - | - | 22.194 | 49.836 | 60.973 | - | - | 60.469 | 60.285 | 61.517 |
| Income in Advance | - | - | 0 | 0 | 0 | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4719 - 4719" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Mdy Bio Dorady Srl